The Obesity-Survival Paradox in Hemodialysis Patients: Why Do Overweight Hemodialysis Patients Live Longer?

Abstract

Obesity is increasingly common in the United States, and it frequently coexists with diabetes and hypertension. Given that diabetes and hypertension are the 2 most common causes of end-stage renal disease, it is not surprising that obesity is also highly prevalent in the US hemodialysis population. However, unlike in the general population, obesity is associated with improved survival in hemodialysis patients. This phenomenon, the obesity-survival paradox, is neither universally accepted nor completely understood. In this article, we review the available data and provide potential reasons for the obesity-survival paradox in the dialysis population.

Get full access to this article

View all access options for this article.

References

Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J III. Hazards of obesity: the Framingham experience. Acta Med Scand. 1988 ;723(suppl):S23– S36.

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097– 1105.

Hsu C, McCulloch C, Iribarren C, Darbinian J, Go A. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006 ;144:21– 28.

Degoulet P, Legrain M, Reach I, et al. Mortality risk factors in patients treated by chronic hemodialysis: report of the Diaphane Collaborative Study. Nephron. 1982 ;31:103– 110.

Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998 ;31:997– 1006.

Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999 ;55:1560– 1567.

Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999 ;56:1136– 1148.

Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000;35:80– 88.

Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in “healthier” as compared with“ sicker” haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386– 2394.

10.

Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002 ;13:1061– 1066.

11.

Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis? Kidney Int. 1996 ;55(suppl):S173– S174.

12.

Salem MM, Bower J. Hypertension in the hemodialysis population: any relation to one-year survival? Am J Kidney Dis. 1996 ;28:737– 740.

13.

Zager PG, Nikolic J, Brown RH, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998 ;54:561– 569.

14.

Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999 ;33:507– 517.

15.

Avram MM, Bonomini LV, Sreedhara R, Mittman N. Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis. 1996;28:910– 917.

16.

Fleischmann EH, Bower JD, Salahudeen AK. Are conventional cardiovascular risk 1 factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol. 2001 ;56:221– 230.

17.

Kramer H, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453– 1459.

18.

Kaizu Y, Tsunega Y, Yoneyama T, et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol. 1998 ;50:44– 50.

19.

Combe C, Chauveau P, Laville M, et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis. 2001 ;37(suppl):S81– S88.

20.

Marcen R, Teruel JL, de la Cal MA, Gamez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients: Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant. 1997;12:2324– 2331.

21.

Aslam N, Bernardini J, Fried L, Piraino B. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int. 2002 ;22:191– 196.

22.

Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13:1307– 1320.

23.

Johnson DW, Herzig KA, Purdie DM, et al. Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int. 2000;20:715– 721.

24.

Stidley C, Hunt W, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513– 520.

25.

Salahudeen AK, Fleischmann EH, Bower JD, Hall JE. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs. BMI in haemodialysis population. Nephrol Dial Transplant. 2004;19:427– 432.

26.

Ishimura E, Okuno S, Marukawa T, et al. Body fat in hemodialysis patients. Am J Kidney Dis. 2003 ;41(suppl 1):S137– S141.

27.

Ohkawa S, Odamaki M, Ikegaya N, Hibi I, Miyaji K, Kumagai H. Association of age with muscle mass, fat mass and fat distribution in non-diabetic haemodialysis patients. Nephrol Dial Transplant. 2005;20:945– 951.

28.

Beddhu S, Pappas L, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366– 2372.

29.

Salahudeen AK, Fleischmann EH, Bower JD. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int. 1999;56:2254– 2259.

30.

Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996 ;50:550– 556.

31.

Ifudu O, Mayers JD, Mathew J, Fowler AM, Homel P, Friedman E. Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass. Ann Intern Med. 1998 ;128:451– 453.

32.

Lowerie E, Li Z, Ofsthun N, Lazarus J. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int. 2002;62:1891– 1897.

33.

Lavie CJ, Milani R, Mehra MR, Ventura HO, Messerli FH. Obesity, weight reduction and survival in heart failure. J Am Coll Cardiol. 2002;39:1563– 1564.

34.

Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002 ;347:305– 313.

35.

Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998 ;338:1– 7.

36.

Fleischmann E, Bower JD, Salahudeen AK. Obesity and survival on hemodialysis: weight gain portends better survival in a prospective cohort [abstract]. J Am Soc Nephrol. 2002 ;13:584A .

37.

Stenvinkel P, Heimburger O, Paultre F. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999 ;55:1899– 1911.

38.

Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int. 1999 ;55:1945– 1951.

39.

Kalantar-Zadeh K, Ikizler T, Block G, Avram M, Kopple J. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 ;42:864– 881.

40.

Kalantar-Zadeh K, Kilpatrick R, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005 ;20:1880– 1888.

41.

Baumgartner R, Wayne S, Waters D, Janssen I, Gallagher D, Morley J. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004 ;12:1995– 2004.

42.

Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001 ;137:231– 243.

43.

Jesus-Gomez G, Santiago-Delp E, Gonzales-Caraballo Z, Morales-Otero L. Study of factors that affect complications after renal transplantation. Transplant Proc. 2006 ;38:911– 913.